{"id":45129,"date":"2026-08-14T20:45:26","date_gmt":"2026-08-14T15:45:26","guid":{"rendered":"https:\/\/usnews-14267fa.ingress-comporellon.ewp.live\/?p=45129"},"modified":"2026-08-14T20:45:26","modified_gmt":"2026-08-14T15:45:26","slug":"the-rise-of-telehealth-pill-mills","status":"publish","type":"post","link":"https:\/\/usnews-14267fa.ingress-comporellon.ewp.live\/?p=45129","title":{"rendered":"The Rise of Telehealth &#039;Pill Mills&#039;"},"content":{"rendered":"<p><script>\r\n  atOptions = {\r\n    'key' : '644b717812d811d6a1c1fc5b6ccd6fa6',\r\n    'format' : 'iframe',\r\n    'height' : 90,\r\n    'width' : 728,\r\n    'params' : {}\r\n  };\r\n<\/script>\r\n<script src=\"https:\/\/www.highperformanceformat.com\/644b717812d811d6a1c1fc5b6ccd6fa6\/invoke.js\"><\/script>\r\n<br \/>\n<\/p>\n<section>\n<figure><img decoding=\"async\" src=\"https:\/\/static.time.com\/v3\/assets\/bltea6093859af6183b\/bltfa8fd767f6ea5dd2\/6a45e66178ebb7d641708df6\/Telehealth_Gold_Rush.png?branch=production\" \/><figcaption> \u2014Photo-Illustration by TIME (Source Image: irynakhabliuk via Canva)<\/figcaption><\/figure>\n<\/section>\n<section>\n<p>The elderly patient\u2019s <a href=\"https:\/\/time.com\/7316703\/heart-health-at-every-decade\/\" target=\"_self\">blood pressure<\/a> had been dropping for weeks, and Chad Wittekind, his primary care provider, couldn\u2019t figure out what was wrong. He had upped the dosage of one medication and added another, but couldn\u2019t manage to regulate it.\u00a0<\/p>\n<p>The patient hadn\u2019t reported taking any other new medications or <a href=\"https:\/\/time.com\/7202466\/best-supplements-to-take-vitamins\/\" target=\"_self\">supplements<\/a> and hadn\u2019t made any major recent lifestyle changes. So what could be causing the blood pressure irregularity?\u00a0<\/p>\n<p>It took a lot of questions and appointments to find the culprit: a drug he\u2019d gotten through a telehealth website.<\/p>\n<p>Like many other patients Wittekind has seen recently, this one had circumvented his primary care provider to get a drug over the Internet\u2014in this case, an erectile-dysfunction medication. He\u2019d gone to a website he came across online, filled out a form that a virtual health care provider quickly reviewed, and was sent the medication through the mail, but had been too embarrassed to tell Wittekind about the new addition to his regimen.\u00a0<\/p>\n<p>You might not think that Wittekind, a Columbus, Ohio-based provider who works in geriatrics, would be seeing many patients turn to the Internet to get drugs for conditions like erectile dysfunction, overweight, <a href=\"https:\/\/time.com\/tag\/menopause\/\" target=\"_self\">menopause<\/a>, and depression. But the accessibility of sites like these and the ease of getting meds from them have made them an increasingly popular choice for Americans of all ages and incomes.<\/p>\n<p>Here\u2019s how it works: often after viewing an ad on social media, people click on little-known websites promising a fast and easy way to get medication for a specific condition. These sites accept credit cards, don\u2019t take insurance, and don\u2019t typically make you have a call with a doctor. Instead, you fill out a quick form about your medical history and current medications, and a medical provider you\u2019ll never meet (and will probably never talk to) reviews the information within minutes to hours. If you qualify, they\u2019ll write you a prescription\u2014often a recurring one\u2014and connect you to a pharmacy that ships the drug directly to your home.<\/p>\n<p>Wittekind and other providers see this as a problem. They\u2019re used to patients coming to them asking for some drug they\u2019ve seen advertised on TV, but the fact that patients can now get these drugs elsewhere, without much screening, is worrying. Wittekind has had a patient receive <a href=\"https:\/\/time.com\/collections\/davos-2020-mental-health\/4876098\/new-hope-for-depression\/\" target=\"_self\">ketamine<\/a> tablets through a telehealth website, and another got a <a href=\"https:\/\/time.com\/7207986\/health-risks-benefits-weight-loss-drugs-ozempic-wegovy\/\" target=\"_self\">GLP-1 drug<\/a> for weight-loss even though they had a BMI of 18.7, meaning they should have been too thin to qualify per U.S. Food and Drug Administration (FDA) <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11324493\/\">guidelines<\/a>. Sometimes, patients will have side effects from medications, but when they follow up with the virtual doctor who prescribed them, they don\u2019t get a helpful response.\u00a0<\/p>\n<p>Sites like these fall under the large umbrella of telehealth, which has unquestionably improved access to medical care, getting services to people who may not be able to easily or quickly find a doctor. It\u2019s also made people much more comfortable seeking treatment for conditions that they might be embarrassed to bring up with their regular doctor, such as erectile dysfunction or <a href=\"https:\/\/time.com\/6997830\/how-much-hair-loss-is-normal-women-aging\/\" target=\"_self\">hair loss<\/a>. But telehealth has changed a lot since it started, when it usually referred to a video call with your doctor. Now, it includes hundreds of websites and the pharmacies they partner with\u2014many of which are under-regulated.\u00a0<\/p>\n<p>\u201cThere\u2019s no accountability, no follow-up if they do have a problem. Trying to get back with their provider is impossible, and then it becomes my problem,\u201d Wittekind says. \u201cThere\u2019s no oversight with most of these places. Yes, you\u2019re improving access, but at what cost?\u201d<\/p>\n<h2><strong>Why telehealth sites are exploding<\/strong><\/h2>\n<p>Elliot Tabibian started his first telehealth site when he was just 18 years old. You don\u2019t need to be a doctor to do so; all you have to do is figure out a condition that people are seeking treatment for and market your website. Outside companies have popped up to help with the infrastructure side\u2014connecting patients with doctors and pharmacies, for example, and ensuring that the website complies with various state and federal laws.\u00a0<\/p>\n<p>Tabibian says he got into telehealth after hearing about a friend who paid a website $200, had a 30-second doctor&#8217;s appointment by phone, and got a medical marijuana card. \u201cI thought, \u2018that seems pretty profitable, I should get in there,\u2019 says Tabibian, who is now 22.<\/p>\n<p>His first site prescribed medical marijuana; he also tried out sites that sold erectile dysfunction medicines and ones that allowed people to get doctor\u2019s notes stating that they needed service animals. (He shut these sites down after competition got too tight, he says.) He now operates two telehealth sites, one of which helps people get medical exemptions so that they can tint their car windows. \u201cTired of Cops Taking Your Tint? See if you Qualify for a Medical Tint Exemption in Less than 10 Minutes!\u201d the site reads. It claims to give customers a full refund if they do not get approved for an exemption.\u00a0<\/p>\n<p>Tabibian\u2019s is one of hundreds, if not thousands, of telehealth sites that have proliferated in recent years. Though some of the first direct-to-consumer telehealth sites started operating before the pandemic, consumers really started embracing telehealth during it, when many insurers loosened restrictions to ensure more patients had access to care. This allowed medical care to be delivered at home to people who might not be able to travel to receive it elsewhere, expanding access. But what was meant to be a temporary measure became permanent as people grew accustomed to the convenience.<\/p>\n<p>As more people sought out telehealth, entrepreneurs like Tabibian stepped in. They were enabled by companies forming networks of doctors that telehealth companies could contract with to provide services to patients, says Rebecca Gwilt, managing partner of Elevare Law, which consults with digital health care companies.\u00a0 An entrepreneur only has to create a website and market its services to get a telehealth company off the ground.<\/p>\n<p>These sites became extremely popular once the first GLP-1s debuted in 2021 and immediately went into shortage. People wanted GLP-1s, and many either couldn\u2019t get them or couldn\u2019t afford them. Telehealth entrepreneurs saw an opportunity, Gwilt says. They partnered with a special type of pharmacy, called a compounding pharmacy, that mixed the active ingredients in GLP-1s and sold them for much less than the pharmaceutical companies.<\/p>\n<p>These sites take advantage of several weaknesses in the American medical system. It is expensive and inconvenient to go to the doctor, and patients often need to <a href=\"https:\/\/www.beckershospitalreview.com\/strategy\/the-38-day-delay-what-the-wait-time-average-says-about-healthcare-access\/\">wait more than a month<\/a> for an appointment. Insurance is also dismal to deal with, and deductibles and pre-approvals can make getting medications a costly headache.\u00a0\u00a0<\/p>\n<p>Those issues \u201ccreated a gap that the compounding pharmacies and telehealth facilities were able to step into,\u201d says Dr. Anjali Deshmukh, a pediatrician who is also a professor of health law at Seton Hall University. \u201cThey did not create the problem, but they are unquestionably profiting.\u201d<\/p>\n<p>One of the companies that helps entrepreneurs start their own telehealth sites is CareValidate. Co-founder Dr. Jiten Chhabra says he has seen a huge surge of people getting into telehealth\u2014even those \u201cwho have no business in telehealth.\u201d CareValidate is growing 20% month over month, he says, buoyed by investors and doctors interested in the idea of cash pay for medical care and specific medications.\u00a0<\/p>\n<p>\u201cWe\u2019re about to see a telehealth site for everything\u2014it\u2019s going to be very niche,\u201d he says. \u201cIt\u2019s going to show up in your social media, and it\u2019s going to be the easiest way to get your hyper-personalized health condition taken care of.\u201d<\/p>\n<p>There are now virtual companies where customers can get diagnoses and prescriptions for things like <a href=\"https:\/\/time.com\/article\/2026\/07\/17\/what-urologists-think-of-military-pete-hegseth-testosterone-testing-policy\/\" target=\"_self\">low testosterone<\/a>, toenail fungus, and even fear of public speaking. Often, the medicines are prescribed on a recurring basis, creating a long-term demand for the services of the telehealth doctor\u2014and revenue streams for investors. These sites have essentially changed the power dynamic between doctors and patients; now, it\u2019s the patients demanding medications they\u2019ve decided they need from online health care providers, rather than patients asking doctors about what\u2019s best for them.\u00a0\u00a0<\/p>\n<p>Investors see a huge upside because the sites are relatively cheap to launch and because they can turn a profit quickly\u2014either by charging people for visits, selling medications at a markup, or both. <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11387907\/\">Venture capitalists<\/a> and <a href=\"https:\/\/www.pehub.com\/pe-hones-in-on-telehealth-demand-5-deals\/\">private equity<\/a> groups have put millions into telehealth startups, some of which have only <a href=\"https:\/\/www.nytimes.com\/2026\/04\/02\/technology\/ai-billion-dollar-company-medvi.html\">a few employees<\/a>. The size of the U.S. telehealth market was an estimated <a href=\"https:\/\/www.grandviewresearch.com\/industry-analysis\/us-telehealth-market\">$28.3 billion in 2025<\/a>, according to Grand View Research, and is projected to grow to $60.4 billion by 2033. The telehealth boom is concentrated in the U.S., where the high cost of medications and medical care has driven many consumers to telehealth sites; the market is not as strong in other countries.\u00a0<\/p>\n<p>The telehealth space is expected to further explode because of interest in peptides, the injectable compounds that wellness influencers have popularized. (Very few\u00a0clinical studies prove that peptides are effective, aside from those for GLP-1s, one example of\u00a0 a peptide.) In a two-day<strong> <\/strong>July hearing, a FDA <a href=\"https:\/\/time.com\/article\/2026\/07\/23\/fda-committee-peptides\/\">committee recommended<\/a> that the agency allow specialty pharmacies to dispense six peptides; if approval is finalized, many patients are expected to get their prescriptions from telehealth sites.\u00a0<\/p>\n<p>Telehealth can be appealing to doctors who are burned out from long hours and negotiating with insurance companies. With telehealth, they can work from home and often avoid insurance altogether.<\/p>\n<p>\u201cThe economics are good, the lifestyle is good,\u201d says Chhabra.<\/p>\n<h2>The problems with this type of telehealth<\/h2>\n<p>The downsides of this direct-to-patient model are starting to become evident. Patients who claim they were prescribed medicines after a cursory online evaluation are filing lawsuits about unanticipated side effects. Several lawsuits allege problems with telehealth companies prescribing at-home <a href=\"https:\/\/www.wsj.com\/health\/wellness\/ketamine-telehealth-dangers-4a7bc8da\">ketamine<\/a>, <a href=\"https:\/\/www.reuters.com\/legal\/government\/telehealth-startup-had-plan-adhd-drugs-now-two-executives-face-criminal-trial-2025-10-10\/\">Adderall<\/a>, and <a href=\"https:\/\/www.wsj.com\/health\/pharma\/telehealth-hims-hair-loss-finasteride-side-effects-0bc5992f\">hair-loss drugs<\/a>.<\/p>\n<p>In a <a href=\"https:\/\/bhbusiness.com\/2025\/11\/03\/mindbloom-faces-wrongful-death-lawsuit-involving-at-home-ketamine-overdose\/\">few<\/a><a href=\"https:\/\/www.wsj.com\/health\/wellness\/ketamine-telehealth-dangers-4a7bc8da\"> cases<\/a>, patients have <a href=\"https:\/\/sgb-law.com\/news\/family-alleges-hims-and-hers-health-incs-rush-into-mental-healthcare-violated-washington-law-and-resulted-in-sons-death\">died<\/a> after receiving what their families allege were inadequate telehealth services. Some lawsuits are also <a href=\"https:\/\/www.courthousenews.com\/eli-lilly-can-proceed-with-lawsuit-against-telehealth-seller-of-weight-loss-drugs\/\">accusing <\/a>telehealth sites of pressuring doctors to act in ways that maximize profit, rather than patient health.<\/p>\n<p>Research suggests that the level of care provided by some of these sites is sometimes poor. In one July 2026 <a href=\"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2851149?guestAccessKey=fa92b2cf-8029-44c4-a5ea-da5b3d264967\">study<\/a> published in <em>JAMA<\/em>, a researcher attempted to obtain prescriptions from 49 telehealth websites and found that there was \u201climited clinician engagement\u201d and that the sites sometimes issued prescriptions, often in as little as five minutes, despite patients not uploading required photos or following other rules of the sites. In some cases, the same clinician provided several different prescriptions for the same patient across multiple sites.<\/p>\n<p>\u201cWhat we found is really there&#8217;s not any sort of true engagement with a clinician,\u201d says Dr. Reshma Ramachandran, a Yale professor and clinician and one of the authors of the study.\u00a0 \u201cThe motivation from these websites is just to prescribe and not necessarily provide health care in the sense of someone actually conveying to that patient the risks and benefits we need to be considering.\u201d\u00a0\u00a0<\/p>\n<p>Because so many sites compete to attract customers, experts say that some doctors are unlikely to turn down requests. Doctors sometimes have quotas of prescriptions they need to meet from the sites or get bonuses for meeting certain goals, says Ramachandran, who has friends who work for telehealth sites. A recent <a href=\"https:\/\/www.durbin.senate.gov\/newsroom\/press-releases\/durbin-sanders-warren-welch-release-investigative-report-on-pharmas-new-direct-to-consumer-telehealth-platforms\">Senate investigation<\/a> into a handful of telehealth sites found that 85%-100% of patients who interacted with a provider received prescriptions.\u00a0<\/p>\n<p>Many patients report that there\u2019s little follow-up from the sites or the doctors they employ, making it difficult for people to know what to do if they develop side effects. Ramachandran, who works at a federally qualified health center for low-income patients, says she has patients coming in who turned to telehealth because insurance got too expensive and were seeking medication, got confused about the dosage they received, and had bad side effects from the medications they took.\u00a0<\/p>\n<p>\u201cI think we\u2019re undermining trust in the physician-patient relationship,\u201d says Erin Fuse Brown, a professor of health services, policy and practice at the Brown University School of Public Health. She <a href=\"https:\/\/papers.ssrn.com\/sol3\/papers.cfm?abstract_id=6731558\">argues that telehealth sites<\/a> are similar to \u201cpill mills,\u201d where the prescribers generate prescriptions if there is any conceivable reason to do so. \u201cIf you can just go to a website and get the drug you\u2019re seeking after a cursory asynchronous questionnaire, it commercializes medicine in a way that\u2019s a little bit dangerous.\u201d\u00a0<\/p>\n<p>Few laws exist to regulate these sites, which have the ability to claim to just be platforms connecting patients and providers.\u00a0<\/p>\n<p>\u201cThere\u2019s so much money to be made, and so many recent business school graduates running a start-up to get to the next big thing, that this aspect of telemedicine is getting way ahead of regulation, the law, and ethics,\u201d says Arthur Caplan, a professor of bioethics at the NYU Grossman School of Medicine. \u201cIt\u2019s like a gold rush.\u201d<\/p>\n<p>Ramachandran says that while telehealth sites may have started as efforts to increase access to care, many have since incorporated incentives for doctors who get patients to try additional medications or take specific costly tests. Her study found that some sites didn\u2019t disclose that the GLP-1s they sold were compounded and made unsubstantiated efficacy claims.\u00a0<\/p>\n<p>\u201cThere are definitely digital health companies out there that you get concerned are worried about revenue rather than patient care,\u201d says Dr. Suneer Chander, a co-founder of Air Physician Academy, which works to educate doctors about how to ethically enter telehealth. \u201cThat\u2019s the sort of stuff we want doctors to understand before they get into digital health so that they can lead the industry, rather than be told what to do.\u201d\u00a0<\/p>\n<p>Tabibian, for instance, says one of the doctors who works for his company has done 300 asynchronous visits a day, reviewing patients\u2019 requests for medication. The doctor gets paid $20 per review and has made as much as $6,000 a day.\u00a0<\/p>\n<p>Asked if he was worried that 300 prescriptions per day was too many, Tabibian says that it\u2019s up to the doctors to do their due diligence on what\u2019s right for the patients. The way his company is set up, he says, he has no say in any medical decisions. \u201cI\u2019m a technology company. My job is just to connect the patient and physician,\u201d he says. \u201cAnything medical that goes on between the patient and the doctor is 100% the doctor\u2019s responsibility.\u201d\u00a0<\/p>\n<p>He does see other sites bend the rules, he says\u2014prescribing testosterone for men whose levels don\u2019t medically support a prescription, for instance. He got ketamine prescribed for himself online because he was interested in starting a ketamine site, and says that he only took half of what the doctor ordered and was so high he couldn\u2019t get out of bed. \u201cThat\u2019s just a huge liability,\u201d he says.<\/p>\n<p>Succeeding at telehealth is really about being good at marketing, he says, and people\u2014especially young people\u2014who know how to promote sites through social media can cash in. \u201cIt\u2019s really been smooth sailing,\u201d he says. \u201cFrom what I\u2019ve seen, there\u2019s little to no enforcement in the field.\u201d<\/p>\n<h2>Murky regulations\u00a0<\/h2>\n<p>Few regulations guide what doctors can and can\u2019t do via telehealth. Doctors, for instance, must meet what\u2019s called the \u201c<a href=\"https:\/\/www.fsmb.org\/siteassets\/advocacy\/policies\/standards-of-care-policy.pdf\">standard of care<\/a>,\u201d meaning that they are expected to diagnose and treat the patient in the same way other qualified doctors would. But standard-of-care obligations are enforced by medical societies and professional associations, and few have taken steps to punish doctors for not meeting the standard of care through telehealth, says Caplan, the bioethics professor.\u00a0<\/p>\n<p>\u201cI\u2019ve tested the sites, and the longest it took me to get whatever pill was about 35 seconds,\u201d he says. \u201cThere doesn\u2019t seem to be a thorough medical exam happening.\u201d\u00a0<\/p>\n<p>Instead, he says, doctors are prescribing medicine like antidepressants without talking to people to figure out why they might be depressed, or prescribing medications with serious side effects without much warning.\u00a0 Litigation often only comes after something bad has happened, like a death or other adverse event.\u00a0<\/p>\n<p>\u201cI do worry about the fracturing of the medical system more broadly,\u201d says Deshmukh, the Seton Hall professor. \u201cI think having a relationship with a physician who understands you and knows your medical history and can make these decisions together is important.\u201d<\/p>\n<p>State medical boards could step in and discipline doctors who are providing substandard care through telehealth. But \u201cthe investigation capacity is really, really limited, and often they just don\u2019t have the resources,\u201d says Ramachandran, the Yale physician and professor.\u00a0<\/p>\n<p>There are not many existing federal laws that could effectively regulate telehealth, says Fuse Brown, the professor from Brown. A law called the anti-kickback statute makes it illegal to compensate someone to make referrals for something (for example, medications) paid for by a federal health care program. That would presumably prohibit telehealth sites who make money off of prescriptions from paying doctors to make those prescriptions. But the anti-kickback statute only applies to drugs prescribed through federal programs like Medicare and Medicaid, and many of these sites are cash pay, so the statute wouldn\u2019t apply.\u00a0<\/p>\n<p>States could also investigate whether providers who work for these sites are being pressured or incentivized to prescribe more medicines, Fuse Brown, who adds that such pressure could potentially violate state laws.<\/p>\n<p>Even without explicit pressure, telehealth providers know what patients expect of them. Wittekind, the geriatrics provider in Columbus, says he tried out working at a telehealth site after a company pitched him on setting his own hours and making some extra money. But one of his first patients was a man who wanted an oral hair-loss medication that can come with serious side effects, Wittekind says.\u00a0<\/p>\n<p>The patient already had hypertension, and Wittekind didn\u2019t think the drug would be a good solution for him, so he turned down the patient\u2019s request. Wittekind realized that his principles probably led to bad reviews for the telehealth site\u2014the patient seemed \u201cperplexed\u201d by the denial\u2014but he didn\u2019t like the idea of prescribing powerful medications without much opportunity for follow-up. He ultimately decided telehealth wasn\u2019t a good fit for him because of that pressure to give the patients what they want.\u00a0<\/p>\n<p>It wasn\u2019t worth the extra money,\u201d he says. But to many other clinicians, it is.\u00a0<\/p>\n<\/section>\n<script async=\"async\" data-cfasync=\"false\" src=\"https:\/\/pl30214220.effectivecpmnetwork.com\/9ab3d4df8a7e1a6171e16ddbf732cc19\/invoke.js\"><\/script>\r\n<div id=\"container-9ab3d4df8a7e1a6171e16ddbf732cc19\"><\/div>\r\n\n","protected":false},"excerpt":{"rendered":"<p>\u2014Photo-Illustration by TIME (Source Image: irynakhabliuk via Canva) The elderly patient\u2019s blood pressure had been dropping for weeks, and Chad Wittekind, his primary care provider, couldn\u2019t figure out what was wrong. He had upped the dosage of one medication and added another, but couldn\u2019t manage to regulate it.\u00a0 The patient hadn\u2019t reported taking any other&#8230;<\/p>\n","protected":false},"author":1,"featured_media":45130,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/static.time.com\/v3\/assets\/bltea6093859af6183b\/bltfa8fd767f6ea5dd2\/6a45e66178ebb7d641708df6\/Telehealth_Gold_Rush.png?branch=production","fifu_image_alt":"","footnotes":""},"categories":[6],"tags":[],"class_list":["post-45129","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pics-news"],"brizy_media":[],"_links":{"self":[{"href":"https:\/\/usnews-14267fa.ingress-comporellon.ewp.live\/index.php?rest_route=\/wp\/v2\/posts\/45129","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/usnews-14267fa.ingress-comporellon.ewp.live\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/usnews-14267fa.ingress-comporellon.ewp.live\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/usnews-14267fa.ingress-comporellon.ewp.live\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/usnews-14267fa.ingress-comporellon.ewp.live\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=45129"}],"version-history":[{"count":0,"href":"https:\/\/usnews-14267fa.ingress-comporellon.ewp.live\/index.php?rest_route=\/wp\/v2\/posts\/45129\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/usnews-14267fa.ingress-comporellon.ewp.live\/index.php?rest_route=\/wp\/v2\/media\/45130"}],"wp:attachment":[{"href":"https:\/\/usnews-14267fa.ingress-comporellon.ewp.live\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=45129"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/usnews-14267fa.ingress-comporellon.ewp.live\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=45129"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/usnews-14267fa.ingress-comporellon.ewp.live\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=45129"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}